Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Avricore Health Inc. (AVCR.V)

TSXV - TSXV Real Time Price. Currency in CAD
0.3450+0.0150 (+4.55%)
At close: 03:59PM EST
Advertisement
Full screen
Loading interactive chart...
  • News Direct

    Avricore Health looks to continue positive growth in 2023 after success in 2022

    Avricore Health CEO Hector Bremner joined Proactive's Steve Darling with an update on the company's 2022 performance and the goals it has set for 2023.

  • GlobeNewswire

    Avricore Health Corporate Update – Earnings Advisory 2022 and 2023 Objectives

    VANCOUVER, British Columbia, Feb. 01, 2023 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) is entering the second year of a multi-year growth plan to bring HealthTab, its turnkey solution for point of care testing and data management, to more pharmacies across Canada and the world. As part of this effort the Company is pleased to provide insight into the successes of last year and lay out updates and objectives on further progress. “Last year we set out bold targe

  • GlobeNewswire

    Avricore Health Reports Third-Quarter 2022 Results

    VANCOUVER, British Columbia, Nov. 29, 2022 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) (the "Company" or “AVCR”) today released its Q3 results which demonstrate significant revenue growth, indicating it can scale sustainably and deliver on its long-term objectives. The Company’s objective to create the world’s first cloud-connected point-of-care network in community pharmacy is on track to becoming a reality, bringing powerful health screening and data management tools to community pha

Advertisement
Advertisement